Physician profile
Dan Jefferies
NPI 1457473738
$2,942.88
in general payments reported to CMS, 2019-2025
17 companies · $394 in 2025
The $394 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $235 · 2020: $57.33 · 2021: $551 · 2022: $667 · 2023: $896 · 2024: $143 · 2025: $394.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,299 · Entertainment: $116 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,298.84 |
| Entertainment | $116.03 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $751.24 | 2022-2025 | Infuse, Miebo, Xiidra |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $284.07 | 2019-2021 | |
| Dompe US, INC. | $246.41 | 2021-2024 | Oxervate |
| Johnson & Johnson Vision Care, INC. | $232.55 | 2021-2023 | Acuvue |
| Alcon Vision LLC | $216.84 | 2022-2025 | Precision7 |
| Ocular Therapeutix, INC. | $179.62 | 2022-2023 | Dextenza |
| Abbvie INC. | $168.15 | 2022-2025 | |
| Allergan, INC. | $164.34 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $121.66 | 2023 | Cequa |
| Optos, INC. | $116.03 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Coopervision INC. | $103.62 | 2023 | Myday Contact Lens |
| Sight Sciences, INC. | $100.38 | 2022 | |
| Kala Pharmaceuticals, INC. | $95.57 | 2020-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $89.07 | 2021-2022 | |
| Visionix USA, INC | $35.19 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Aerie Pharmaceuticals, INC. | $18.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dan Jefferies listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.